RecruitingNCT06744985

Comparison of RTS and MGAP Scores in Predicting Outcomes of Trauma Patients

Mortality Prediction in Multiple Trauma Patients: A Comparison of the Revised Trauma Score and MGAP Score at a Trauma Center


Sponsor

Al-Nahrain University

Enrollment

200 participants

Start Date

Jan 20, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this prospective cohort study is to compare the predictive accuracy of the Revised Trauma Score (RTS) and the MGAP score in determining clinical outcomes among multiple trauma patients hospitalized at a trauma center in Iraq. The main questions it aims to answer are: Which score, RTS or MGAP, provides a more accurate prediction of clinical outcomes, including mortality? Are there specific subgroups of trauma patients where one scoring system outperforms the other? Participants will: Be assessed using both the RTS and MGAP scores upon admission. Have their clinical outcomes, including mortality and other relevant indicators, monitored throughout their hospital stay.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Presentation to the trauma center within 6 hours of injury.
  • Availability of complete clinical and demographic data for scoring using RTS and MGAP.
  • Patients who consent to participate in the study or whose legal representatives provide consent.
  • Capability to assess outcomes such as survival, ICU admission, and complications.

Exclusion Criteria4

  • Patients who expired before scoring or evaluation
  • Missing or unreliable medical data for RTS or MGAP score calculations.
  • Transfers from other facilities with interventions that could impact RTS or MGAP reliability.
  • Pregnant patients, due to the unique considerations of trauma in pregnancy.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

College of Medicine - Al-Nahrain University

Baghdad, Iraq

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06744985


Related Trials